Dr. Marwan Samir Ghabril, MD

Dr. Ghabril practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Ghabril's NPI, 1366431231, was assigned on October 13, 2005. Dr. Ghabril holds Indiana license 01064994A.

Dr. Ghabril's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Ghabril's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Ghabril is also affiliated with IU Health Ball Memorial Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Ghabril to 3 more hospitals, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghabril practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ghabril's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ghabril is licensed in Indiana.

CMS data shows 354 Medicare services from Dr. Ghabril across 7 procedure codes in 2024, for 137 Medicare patients. Medicare paid $18,819 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 137 Medicare patients who saw Dr. Ghabril in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghabril's median patient age at 60, with 48% women.

In 2024, Dr. Ghabril wrote 1,089 Medicare Part D claims for 170 patients. 93% of them were for generic drugs. CMS names the drug for 893 of them, across 20 drugs with 11 or more claims each, at $275,975 in total drug cost. In 2023, CMS named 652 claims across 14 drugs.

Dr. Ghabril accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ghabril as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 156 papers to Dr. Ghabril, published from 2011 to 2025. 2022 was the busiest year, with 19. The most frequent topics are Liver Cirrhosis, Liver Transplantation and Chemical and Drug Induced Liver Injury. Dr. Ghabril has published most often in Dig Dis Sci. Dr. Ghabril's most frequent co-authors are Naga Prasad Chalasani, MD, Eric S. Orman, MD and Archita Parikh Desai, MD.

Dmand AI links Dr. Ghabril to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include COVID-19, Hepatic Encephalopathy and Liver Cirrhosis. Open Payments lists research payments to Dr. Ghabril that name 1 trial.

CMS Open Payments shows 8 general payments to Dr. Ghabril from 6 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 74% of the total. BioCryst Pharmaceuticals, Inc. paid the most, $9,900. It also lists 2 research payments totaling $23,393 from 2016 to 2022, naming 1 clinical trial.